BCAX vs SHOP · $1.51B cap vs P/E 107, rev $3.58B
Bicara Therapeutics Inc. Common Stock (BCAX) versus Shopify Inc (SHOP) — a side-by-side from cached financials, not a winner call.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
Shopify Inc (SHOP) is a software - application company listed on US. It is led by Tobi Lutke.
BCAX does not have a complete income-statement cache yet.
Latest reported SHOP revenue for 2026-06-30 was $3.58B. Net income was $1.50B. Revenue was up 13.0% from 2026-03-31 to 2026-06-30. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
BCAX currently screens at market cap $1.51B. SHOP currently screens at market cap $142.15B and trailing P/E 107.4.
Not investment advice. Open the BCAX and SHOP stock pages for the full models.
Not investment advice.